Article
Medulloblastoma: Molecular Classification-Based Personal Therapeutics.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics - 1 Apr 2017
Archer Tenley C, Mahoney Elizabeth L, Pomeroy Scott L
Abstract excerpt
Recent advances in cancer genomics have revealed 4 distinct subgroups of medulloblastomas, each with unique transcription profiles, DNA alterations and clinical outcome. Molecular classification of medulloblastomas improves predictions of clinical outcome, allowing more accurate matching of intensity of conventional treatments with chemotherapy and radiation to overall prognosis and setting the stage for the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
